1.
Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment
by GYLLING, H
Diabetologia, 1994, Vol.37 (8), p.773-780
2.
High Density Lipoprotein Turnover in Patients With Hypertension
by Chen, Y-D Ida
Hypertension (Dallas, Tex. 1979), 1991-03, Vol.17 (3), p.386-393
3.
Changes in Lipoprotein Kinetics Associated With Type 2 Diabetes Affect the Distribution of Lipopolysaccharides Among Lipoproteins
by Vergès, Bruno
The journal of clinical endocrinology and metabolism, 2014-07, Vol.99 (7), p.E1245-E1253
4.
Overproduction of large VLDL particles is driven by increased liver fat content in man
by ADIELS, M
Diabetologia, 2006, Vol.49 (4), p.755-765
5.
ANGPTL8 Blockade With a Monoclonal Antibody Promotes Triglyceride Clearance, Energy Expenditure, and Weight Loss in Mice
by Gusarova, Viktoria
Endocrinology (Philadelphia), 2017-05-01, Vol.158 (5), p.1252-1259
6.
Exercise Training Reduces Liver Fat and Increases Rates of VLDL Clearance But Not VLDL Production in NAFLD
by Shojaee-Moradie, F
The journal of clinical endocrinology and metabolism, 2016-11, Vol.101 (11), p.4219-4228
7.
Mechanism of Action of a Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist on Lipoprotein Metabolism in Dyslipidemic Subjects with Central Obesity
by Ooi, Esther M. M
The journal of clinical endocrinology and metabolism, 2011-10, Vol.96 (10), p.E1568-E1576
8.
Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-controlled Type 2 Diabetes
by Kashyap, Sangeeta R
The journal of clinical endocrinology and metabolism, 2017-10-26, Vol.103 (2), p.388-396
9.
Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a
by Bandsma, Robert H J
Pediatric research, 2008-06, Vol.63 (6), p.702-707
10.
ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity
by Vergès, Bruno
The journal of clinical endocrinology and metabolism, 2016-04, Vol.101 (4), p.1398-1406
11.
VLDL Triglyceride Kinetics in Lean, Overweight, and Obese Men and Women
by Mittendorfer, Bettina
The journal of clinical endocrinology and metabolism, 2016-11, Vol.101 (11), p.4151-4160
12.
Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes
by Vergès, B
Diabetologia, 2008-06-05, Vol.51 (8), p.1382-1390
13.
Sex Differences in Lipid and Lipoprotein Metabolism: It's Not Just about Sex Hormones
by Wang, Xuewen
The journal of clinical endocrinology and metabolism, 2011-04, Vol.96 (4), p.885-893
14.
Adsorption kinetics of low-density lipoproteins with Langmuir monolayer
by Khattari, Ziad
Journal of biological physics, 2016-07-19, Vol.42 (4), p.539-550
15.
Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance
by ADIELS, M
Diabetologia, 2007, Vol.50 (11), p.2356-2365
16.
Energy demands during a judo match and recovery
by Degoutte, F
British journal of sports medicine, 2003-06, Vol.37 (3), p.245-249
17.
Time-course changes in circulating branched-chain amino acid levels and metabolism in obese Yucatan minipig
by Polakof, Sergio
Nutrition (Burbank, Los Angeles County, Calif.), 2017, Vol.50, p.66-73
18.
Impaired Insulin Suppression of VLDL-Triglyceride Kinetics in Nonalcoholic Fatty Liver Disease
by Poulsen, Marianne K
The journal of clinical endocrinology and metabolism, 2016-04, Vol.101 (4), p.1637-1646
19.
20.
Effect of Fenofibrate and Niacin on Intrahepatic Triglyceride Content, Very Low-Density Lipoprotein Kinetics, and Insulin Action in Obese Subjects with Nonalcoholic Fatty Liver Dis...
by Fabbrini, Elisa
The journal of clinical endocrinology and metabolism, 2010-06, Vol.95 (6), p.2727-2735
